Covid-19 Neurology News

WFN Department Visit and Training Centres Programme Suspended Due to Covid-19

3 Apr 2020

Sadly, due to the global COVID-19 pandemic we are suspending the announcements of any new Department Visit and Training Centre Programmes. We plan to be able to bring these back to you in due course.

Guidance management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

2 Apr 2020

No data currently exist on how COVID-19 affects people with myasthenia gravis (MG)/LEMS or patients with other diseases on immunosuppressive therapies. However, because most patients with MG are on immunosuppressive or immunomodulatory therapies and may also have respiratory muscle weakness, there is a theoretical concern that MG/LEMS patients may be at higher risk of contracting the infection or experiencing severe manifestations of COVID-19.

Lost Smell and Taste Hint COVID-19 Can Target the Nervous System

24 Mar 2020

The symptoms suggest SARS-CoV-2 might infect neurons, raising questions about whether there could be effects on the brain that play a role in patients’ deaths, but the data are preliminary.

AAN leading telehealth efforts to fight COVID-19

23 Mar 2020

The AAN announced a new COVID-19 Neurology Resource Center, a one-stop-shop for the latest resources and guidance from the AAN and other trusted organizations to help you care for neurologic patients during the COVID-19 pandemic.  Topics include the latest COVID-19 articles and publications, practice resources, and advocacy actions you can take. Register for the AAN’s free Telemedicine and COVID-19 webinar on March 26.

EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19 Share

18 Mar 2020

There is currently no scientific evidence establishing a link between ibuprofen and worsening of COVID‑19. 

2020 AAN Annual Meeting Canceled Due to COVID-19 Pandemic

13 Mar 2020

Due to the global COVID-19 (Coronavirus) pandemic, the American Academy of Neurology announced March 13, 2020, that it has no choice but to make the necessary decision to cancel the AAN’s Annual Meeting originally scheduled for April 25–May 1, 2020, in Toronto.

1 3